av/amphastar-pharmaceuticals--big.svg

NASDAQ:AMPH

Amphastar Pharmaceuticals

  • Stock

23.88

−2.17%

2.67

USD last updated 03/08 01:57:01

Last Close

21.21

01/08 20:01

Market Cap

1.83B

Beta: 0.76

Volume Today

542.69K

Avg: 335.69K

PE Ratio

18.88

PFCF: 17.97

OverviewFinancialsAPI

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

    Description

    Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-counter epinephrine inhalation product...Show More

    Excel Tearsheet

    Earnings

    Earnings per Share (Estimate*)

    -0.20.20.40.60.811.22018-03-122020-03-122021-11-082023-11-082024-11-06

    Revenue (Estimate*)

    50M100M150M200M2018-03-122020-03-122021-11-082023-11-082024-11-06

    *Estimate based on analyst consensus